Invest in the Future of Precision Brain Health

Encephalon Biotech is redefining the landscape of neuroscience through scalable, data-driven research platforms that bring diagnostics and therapeutics closer to patients. By investing in our mission, you help accelerate global access to early detection, equitable research, and transformative brain health innovation.

Why Invest in Encephalon Biotech

Encephalon Biotech stands at the intersection of science, technology, and healthcare — combining world-class neuroscience research with a sustainable, partnership-based model. Our unique approach bridges primary care, academia, and biotech innovation to deliver measurable impact.

Core Strengths

  • Proven leadership under Dr Sid, a global authority in Alzheimer’s and neurodegenerative research.
  • Multi-site, trial-ready cohorts accelerating clinical validation.
  • Established partnerships across academia, healthcare, and diagnostics sectors.
  • Scalable business model through exclusive and expansion licensing.
Our precision-based platform generates real-world data, enabling faster approvals, lower trial costs, and broader market adoption.

Market Opportunity

Dr Sid: Market Opportunity

The global brain health market is expanding rapidly, driven by aging populations and rising neurological conditions. Yet, traditional research pipelines remain slow and inaccessible.

"By embedding Alzheimer’s and cognitive research directly in primary care, we reach millions earlier and create opportunities for earlier detection and intervention."
  • Global dementia market projected to exceed $18 billion by 2030.
  • Alzheimer’s diagnostics sector growing at 8.7% CAGR.
  • Rising demand for biomarker-based precision tools.
  • Increasing investment in AI and data-driven healthcare platforms

Our hybrid model blends scientific integrity with sustainable growth. We generate revenue through data licensing, strategic sponsorships, and site expansion programs — ensuring scalability and long-term impact.

Revenue Streams:
  • Exclusive Licensing — Partner access to proprietary datasets and biorepositories.
  • Expansion Licensing — Global in-licensing of validated research SOPs and frameworks
  • Sponsorship Programs — Industry-funded initiatives supporting PCAN and Veterans Brain Health Networks.
  • Collaborative Research — Co-funded studies with academic and industry partners.
Key Differentiators:
  • Pioneering Precision Brain Health platform integrating real-world primary care data.
  • 2,000+ participants enrolled in flagship E-ADPC Study.
  • Inclusive and global expansion through Africa and Panama TRCs.
  • Proven reduction in trial time and cost per enrollment.
  • Ethical, equity-driven research model ensuring sustainability and diversity.

Strategic Growth Opportunities

Encephalon Biotech offers scalable opportunities for investors and strategic collaborators seeking to participate in the rapid evolution of neuroscience innovation. Our model is designed for sustainable growth. From expanding research networks to commercializing validated diagnostic and therapeutic tools.

Opportunities Include:
  • Investment in precision diagnostics and AI-driven cognitive tools.
  • Funding support for trial-ready cohort expansion (E-ADPC, E-TRC, PCAN).
  • Co-development of new biomarker technologies and clinical applications
  • Participation in international site expansion through licensing or equity partnerships.